Covid-19 Impact on Global Immuno-Oncology Market Size, Status and Forecast 2020-2026

Covid-19 Impact on Global Immuno-Oncology Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Immuno-Oncology Revenue
1.4 Market Analysis by Type
1.4.1 Global Immuno-Oncology Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Immune Checkpoint Inhibitors
1.4.3 Cytokine-Based Immunotherapy
1.4.4 Cancer Vaccines
1.4.5 CAR-T Cell Therapy
1.4.6 Others
1.5 Market by Application
1.5.1 Global Immuno-Oncology Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Drugstores
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Immuno-Oncology Industry Impact
1.6.1 How the Covid-19 is Affecting the Immuno-Oncology Industry
1.6.1.1 Immuno-Oncology Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Immuno-Oncology Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Immuno-Oncology Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Immuno-Oncology Market Perspective (2015-2026)
2.2 Immuno-Oncology Growth Trends by Regions
2.2.1 Immuno-Oncology Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Immuno-Oncology Historic Market Share by Regions (2015-2020)
2.2.3 Immuno-Oncology Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Immuno-Oncology Market Growth Strategy
2.3.6 Primary Interviews with Key Immuno-Oncology Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Immuno-Oncology Players by Market Size
3.1.1 Global Top Immuno-Oncology Players by Revenue (2015-2020)
3.1.2 Global Immuno-Oncology Revenue Market Share by Players (2015-2020)
3.1.3 Global Immuno-Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Immuno-Oncology Market Concentration Ratio
3.2.1 Global Immuno-Oncology Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Immuno-Oncology Revenue in 2019
3.3 Immuno-Oncology Key Players Head office and Area Served
3.4 Key Players Immuno-Oncology Product Solution and Service
3.5 Date of Enter into Immuno-Oncology Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Immuno-Oncology Historic Market Size by Type (2015-2020)
4.2 Global Immuno-Oncology Forecasted Market Size by Type (2021-2026)
5 Immuno-Oncology Breakdown Data by Application (2015-2026)
5.1 Global Immuno-Oncology Market Size by Application (2015-2020)
5.2 Global Immuno-Oncology Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Immuno-Oncology Market Size (2015-2020)
6.2 Immuno-Oncology Key Players in North America (2019-2020)
6.3 North America Immuno-Oncology Market Size by Type (2015-2020)
6.4 North America Immuno-Oncology Market Size by Application (2015-2020)
7 Europe
7.1 Europe Immuno-Oncology Market Size (2015-2020)
7.2 Immuno-Oncology Key Players in Europe (2019-2020)
7.3 Europe Immuno-Oncology Market Size by Type (2015-2020)
7.4 Europe Immuno-Oncology Market Size by Application (2015-2020)
8 China
8.1 China Immuno-Oncology Market Size (2015-2020)
8.2 Immuno-Oncology Key Players in China (2019-2020)
8.3 China Immuno-Oncology Market Size by Type (2015-2020)
8.4 China Immuno-Oncology Market Size by Application (2015-2020)
9 Japan
9.1 Japan Immuno-Oncology Market Size (2015-2020)
9.2 Immuno-Oncology Key Players in Japan (2019-2020)
9.3 Japan Immuno-Oncology Market Size by Type (2015-2020)
9.4 Japan Immuno-Oncology Market Size by Application (2015-2020)
10 India
10.1 India Immuno-Oncology Market Size (2015-2020)
10.2 Immuno-Oncology Key Players in India (2019-2020)
10.3 India Immuno-Oncology Market Size by Type (2015-2020)
10.4 India Immuno-Oncology Market Size by Application (2015-2020)
11 Southeast Asia
11.1 Southeast Asia Immuno-Oncology Market Size (2015-2020)
11.2 Immuno-Oncology Key Players in Southeast Asia (2019-2020)
11.3 Southeast Asia Immuno-Oncology Market Size by Type (2015-2020)
11.4 Southeast Asia Immuno-Oncology Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Immuno-Oncology Market Size (2015-2020)
12.2 Immuno-Oncology Key Players in Central & South America (2019-2020)
12.3 Central & South America Immuno-Oncology Market Size by Type (2015-2020)
12.4 Central & South America Immuno-Oncology Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Bristol-Myers Squibb
13.1.1 Bristol-Myers Squibb Company Details
13.1.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
13.1.3 Bristol-Myers Squibb Immuno-Oncology Introduction
13.1.4 Bristol-Myers Squibb Revenue in Immuno-Oncology Business (2015-2020))
13.1.5 Bristol-Myers Squibb Recent Development
13.2 Merck & Co., Inc.
13.2.1 Merck & Co., Inc. Company Details
13.2.2 Merck & Co., Inc. Business Overview and Its Total Revenue
13.2.3 Merck & Co., Inc. Immuno-Oncology Introduction
13.2.4 Merck & Co., Inc. Revenue in Immuno-Oncology Business (2015-2020)
13.2.5 Merck & Co., Inc. Recent Development
13.3 Roche AG
13.3.1 Roche AG Company Details
13.3.2 Roche AG Business Overview and Its Total Revenue
13.3.3 Roche AG Immuno-Oncology Introduction
13.3.4 Roche AG Revenue in Immuno-Oncology Business (2015-2020)
13.3.5 Roche AG Recent Development
13.4 AstraZeneca, Plc
13.4.1 AstraZeneca, Plc Company Details
13.4.2 AstraZeneca, Plc Business Overview and Its Total Revenue
13.4.3 AstraZeneca, Plc Immuno-Oncology Introduction
13.4.4 AstraZeneca, Plc Revenue in Immuno-Oncology Business (2015-2020)
13.4.5 AstraZeneca, Plc Recent Development
13.5 Sanofi S.A.
13.5.1 Sanofi S.A. Company Details
13.5.2 Sanofi S.A. Business Overview and Its Total Revenue
13.5.3 Sanofi S.A. Immuno-Oncology Introduction
13.5.4 Sanofi S.A. Revenue in Immuno-Oncology Business (2015-2020)
13.5.5 Sanofi S.A. Recent Development
13.6 Dendreon Pharmaceuticals
13.6.1 Dendreon Pharmaceuticals Company Details
13.6.2 Dendreon Pharmaceuticals Business Overview and Its Total Revenue
13.6.3 Dendreon Pharmaceuticals Immuno-Oncology Introduction
13.6.4 Dendreon Pharmaceuticals Revenue in Immuno-Oncology Business (2015-2020)
13.6.5 Dendreon Pharmaceuticals Recent Development
13.7 Novartis
13.7.1 Novartis Company Details
13.7.2 Novartis Business Overview and Its Total Revenue
13.7.3 Novartis Immuno-Oncology Introduction
13.7.4 Novartis Revenue in Immuno-Oncology Business (2015-2020)
13.7.5 Novartis Recent Development
13.8 Gilead Sciences Inc.
13.8.1 Gilead Sciences Inc. Company Details
13.8.2 Gilead Sciences Inc. Business Overview and Its Total Revenue
13.8.3 Gilead Sciences Inc. Immuno-Oncology Introduction
13.8.4 Gilead Sciences Inc. Revenue in Immuno-Oncology Business (2015-2020)
13.8.5 Gilead Sciences Inc. Recent Development
13.9 Merck KGaA
13.9.1 Merck KGaA Company Details
13.9.2 Merck KGaA Business Overview and Its Total Revenue
13.9.3 Merck KGaA Immuno-Oncology Introduction
13.9.4 Merck KGaA Revenue in Immuno-Oncology Business (2015-2020)
13.9.5 Merck KGaA Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Immuno-Oncology Key Market Segments
Table 2. Key Players Covered: Ranking by Immuno-Oncology Revenue
Table 3. Ranking of Global Top Immuno-Oncology Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Immuno-Oncology Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Immune Checkpoint Inhibitors
Table 6. Key Players of Cytokine-Based Immunotherapy
Table 7. Key Players of Cancer Vaccines
Table 8. Key Players of CAR-T Cell Therapy
Table 9. Key Players of Others
Table 10. COVID-19 Impact Global Market: (Four Immuno-Oncology Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Immuno-Oncology Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Immuno-Oncology Players to Combat Covid-19 Impact
Table 15. Global Immuno-Oncology Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Immuno-Oncology Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Immuno-Oncology Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Immuno-Oncology Market Share by Regions (2015-2020)
Table 19. Global Immuno-Oncology Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Immuno-Oncology Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Immuno-Oncology Market Growth Strategy
Table 25. Main Points Interviewed from Key Immuno-Oncology Players
Table 26. Global Immuno-Oncology Revenue by Players (2015-2020) (Million US$)
Table 27. Global Immuno-Oncology Market Share by Players (2015-2020)
Table 28. Global Top Immuno-Oncology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immuno-Oncology as of 2019)
Table 29. Global Immuno-Oncology by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Immuno-Oncology Product Solution and Service
Table 32. Date of Enter into Immuno-Oncology Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Immuno-Oncology Market Size by Type (2015-2020) (Million US$)
Table 35. Global Immuno-Oncology Market Size Share by Type (2015-2020)
Table 36. Global Immuno-Oncology Revenue Market Share by Type (2021-2026)
Table 37. Global Immuno-Oncology Market Size Share by Application (2015-2020)
Table 38. Global Immuno-Oncology Market Size by Application (2015-2020) (Million US$)
Table 39. Global Immuno-Oncology Market Size Share by Application (2021-2026)
Table 40. North America Key Players Immuno-Oncology Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Immuno-Oncology Market Share (2019-2020)
Table 42. North America Immuno-Oncology Market Size by Type (2015-2020) (Million US$)
Table 43. North America Immuno-Oncology Market Share by Type (2015-2020)
Table 44. North America Immuno-Oncology Market Size by Application (2015-2020) (Million US$)
Table 45. North America Immuno-Oncology Market Share by Application (2015-2020)
Table 46. Europe Key Players Immuno-Oncology Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Immuno-Oncology Market Share (2019-2020)
Table 48. Europe Immuno-Oncology Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Immuno-Oncology Market Share by Type (2015-2020)
Table 50. Europe Immuno-Oncology Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Immuno-Oncology Market Share by Application (2015-2020)
Table 52. China Key Players Immuno-Oncology Revenue (2019-2020) (Million US$)
Table 53. China Key Players Immuno-Oncology Market Share (2019-2020)
Table 54. China Immuno-Oncology Market Size by Type (2015-2020) (Million US$)
Table 55. China Immuno-Oncology Market Share by Type (2015-2020)
Table 56. China Immuno-Oncology Market Size by Application (2015-2020) (Million US$)
Table 57. China Immuno-Oncology Market Share by Application (2015-2020)
Table 58. Japan Key Players Immuno-Oncology Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Immuno-Oncology Market Share (2019-2020)
Table 60. Japan Immuno-Oncology Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Immuno-Oncology Market Share by Type (2015-2020)
Table 62. Japan Immuno-Oncology Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Immuno-Oncology Market Share by Application (2015-2020)
Table 64. India Key Players Immuno-Oncology Revenue (2019-2020) (Million US$)
Table 65. India Key Players Immuno-Oncology Market Share (2019-2020)
Table 66. India Immuno-Oncology Market Size by Type (2015-2020) (Million US$)
Table 67. India Immuno-Oncology Market Share by Type (2015-2020)
Table 68. India Immuno-Oncology Market Size by Application (2015-2020) (Million US$)
Table 69. India Immuno-Oncology Market Share by Application (2015-2020)
Table 70. Southeast Asia Key Players Immuno-Oncology Revenue (2019-2020) (Million US$)
Table 71. Southeast Asia Key Players Immuno-Oncology Market Share (2019-2020)
Table 72. Southeast Asia Immuno-Oncology Market Size by Type (2015-2020) (Million US$)
Table 73. Southeast Asia Immuno-Oncology Market Share by Type (2015-2020)
Table 74. Southeast Asia Immuno-Oncology Market Size by Application (2015-2020) (Million US$)
Table 75. Southeast Asia Immuno-Oncology Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Immuno-Oncology Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Immuno-Oncology Market Share (2019-2020)
Table 78. Central & South America Immuno-Oncology Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Immuno-Oncology Market Share by Type (2015-2020)
Table 80. Central & South America Immuno-Oncology Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Immuno-Oncology Market Share by Application (2015-2020)
Table 82. Bristol-Myers Squibb Company Details
Table 83. Bristol-Myers Squibb Business Overview
Table 84. Bristol-Myers Squibb Product
Table 85. Bristol-Myers Squibb Revenue in Immuno-Oncology Business (2015-2020) (Million US$)
Table 86. Bristol-Myers Squibb Recent Development
Table 87. Merck & Co., Inc. Company Details
Table 88. Merck & Co., Inc. Business Overview
Table 89. Merck & Co., Inc. Product
Table 90. Merck & Co., Inc. Revenue in Immuno-Oncology Business (2015-2020) (Million US$)
Table 91. Merck & Co., Inc. Recent Development
Table 92. Roche AG Company Details
Table 93. Roche AG Business Overview
Table 94. Roche AG Product
Table 95. Roche AG Revenue in Immuno-Oncology Business (2015-2020) (Million US$)
Table 96. Roche AG Recent Development
Table 97. AstraZeneca, Plc Company Details
Table 98. AstraZeneca, Plc Business Overview
Table 99. AstraZeneca, Plc Product
Table 100. AstraZeneca, Plc Revenue in Immuno-Oncology Business (2015-2020) (Million US$)
Table 101. AstraZeneca, Plc Recent Development
Table 102. Sanofi S.A. Company Details
Table 103. Sanofi S.A. Business Overview
Table 104. Sanofi S.A. Product
Table 105. Sanofi S.A. Revenue in Immuno-Oncology Business (2015-2020) (Million US$)
Table 106. Sanofi S.A. Recent Development
Table 107. Dendreon Pharmaceuticals Company Details
Table 108. Dendreon Pharmaceuticals Business Overview
Table 109. Dendreon Pharmaceuticals Product
Table 110. Dendreon Pharmaceuticals Revenue in Immuno-Oncology Business (2015-2020) (Million US$)
Table 111. Dendreon Pharmaceuticals Recent Development
Table 112. Novartis Company Details
Table 113. Novartis Business Overview
Table 114. Novartis Product
Table 115. Novartis Revenue in Immuno-Oncology Business (2015-2020) (Million US$)
Table 116. Novartis Recent Development
Table 117. Gilead Sciences Inc. Business Overview
Table 118. Gilead Sciences Inc. Product
Table 119. Gilead Sciences Inc. Company Details
Table 120. Gilead Sciences Inc. Revenue in Immuno-Oncology Business (2015-2020) (Million US$)
Table 121. Gilead Sciences Inc. Recent Development
Table 122. Merck KGaA Company Details
Table 123. Merck KGaA Business Overview
Table 124. Merck KGaA Product
Table 125. Merck KGaA Revenue in Immuno-Oncology Business (2015-2020) (Million US$)
Table 126. Merck KGaA Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immuno-Oncology Market Share by Type: 2020 VS 2026
Figure 2. Immune Checkpoint Inhibitors Features
Figure 3. Cytokine-Based Immunotherapy Features
Figure 4. Cancer Vaccines Features
Figure 5. CAR-T Cell Therapy Features
Figure 6. Others Features
Figure 7. Global Immuno-Oncology Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Drugstores Case Studies
Figure 10. Others Case Studies
Figure 11. Immuno-Oncology Report Years Considered
Figure 12. Global Immuno-Oncology Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Immuno-Oncology Market Share by Regions: 2020 VS 2026
Figure 14. Global Immuno-Oncology Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Immuno-Oncology Market Share by Players in 2019
Figure 17. Global Top Immuno-Oncology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immuno-Oncology as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Immuno-Oncology Revenue in 2019
Figure 19. North America Immuno-Oncology Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Immuno-Oncology Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Immuno-Oncology Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Immuno-Oncology Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Immuno-Oncology Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Immuno-Oncology Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Immuno-Oncology Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Bristol-Myers Squibb Revenue Growth Rate in Immuno-Oncology Business (2015-2020)
Figure 28. Merck & Co., Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Merck & Co., Inc. Revenue Growth Rate in Immuno-Oncology Business (2015-2020)
Figure 30. Roche AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Roche AG Revenue Growth Rate in Immuno-Oncology Business (2015-2020)
Figure 32. AstraZeneca, Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. AstraZeneca, Plc Revenue Growth Rate in Immuno-Oncology Business (2015-2020)
Figure 34. Sanofi S.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Sanofi S.A. Revenue Growth Rate in Immuno-Oncology Business (2015-2020)
Figure 36. Dendreon Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Dendreon Pharmaceuticals Revenue Growth Rate in Immuno-Oncology Business (2015-2020)
Figure 38. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Novartis Revenue Growth Rate in Immuno-Oncology Business (2015-2020)
Figure 40. Gilead Sciences Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Gilead Sciences Inc. Revenue Growth Rate in Immuno-Oncology Business (2015-2020)
Figure 42. Merck KGaA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Merck KGaA Revenue Growth Rate in Immuno-Oncology Business (2015-2020)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Cancer Immunomodulator Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Cancer Immunomodulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ ......

Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size was valued at US$ 14070 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) is forecast to a readjusted size of US$ 57240 million by 2030 with a CAGR of 22.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells (CTCs) and Canc......

Global Circulating Tumor Cells Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131

According to our LPI (LP Information) latest study, the global Circulating Tumor Cells market size was valued at US$ 1550.1 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells is forecast to a readjusted size of US$ 5942.1 million by 2030 with a CAGR of 21.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells market. Circulating Tumor Cells are expected to show stable growth in the future mark......

Global Circulating Tumor Cells Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 125

According to our (Global Info Research) latest study, the global Circulating Tumor Cells market size was valued at USD 1630.5 million in 2023 and is forecast to a readjusted size of USD 5681.6 million by 2030 with a CAGR of 19.5% during review period. Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of......

Small Molecule Targeted Cancer Therapy - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 112

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Small Molecule Targeted Cancer Therapy, with......

Global Cancer Gene Therapy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Cancer Gene Therapy market: According to our latest research, the global Cancer Gene Therapy market looks promising in the next 5 years. As of 2022, the global Cancer Gene Therapy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Gene Th......

T-Cell Immunotherapy - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 85

CAR T cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively. The global T-Cell Immunotherapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of T-Cell Immunotherapy in various end use industries. The expanding demands from the Stomach ......

Global Kaposi Sarcoma Market Status and Outlook 2023-2028

Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 107

Kaposi's sarcoma is a type of cancer that forms in the lining of blood and lymph vessels. The tumors (lesions) of Kaposi's sarcoma typically appear as painless purplish spots on the legs, feet or face. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking a......

Global Cancer Immunomodulator Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 118

Market Overview of Global Cancer Immunomodulator market: According to our latest research, the global Cancer Immunomodulator market looks promising in the next 5 years. As of 2022, the global Cancer Immunomodulator market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cance......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs